Dentin restoration
Biodentine's unique properties offer superior handling and wear characteristics for exceptional restoration durability. Learn more about this amazing material from Dr. Hei!…
1 minute watch
Prof. Schwendicke
In a time of increasing demand for dental services, demonstrating value means more than just reducing costs. Vital pulp therapy (VPT) offers a biologically driven approach that preserves tooth vitality, limits invasiveness, and helps to keep patients out of the “death spiral” of increasingly complex (and costly) treatments. In this article, conservative dentistry expert Prof. Dr. Falk Schwendicke explores how VPT with Biodentine® delivers long-lasting value, both clinically and economically.
Oral disease remains a significant global public health concern, affecting more than 3.7 billion people worldwide.1 The economic burden is staggering, with a recent study estimating the global cost of oral conditions at $710bn USD in 2019.2 Only 54.5% ($387bn) of this was attributed to direct costs of treatment, highlighting the often-underestimated indirect costs associated with loss of productivity.2
The most prevalent non-communicable disease worldwide, dental caries alone is thought to account for 5-10% of healthcare budgets in industrialised nations.3 This is against a backdrop of unprecedented financial strain on healthcare systems in countries like the United Kingdom, where it was announced in 2024 that the NHS dentistry budget had experienced real-terms cuts of £1bn since 2010.4
When dental need is increasing, but resources are plummeting, there is enormous pressure on dental professionals to demonstrate value for money in their clinical practice. In this article, we invite world-leading experts in dental health economics to explain how treatments like vital pulp therapy with Biodentine® can help.
The primary obligation of a dental professional must always be to strive for the best clinical outcomes for the patient. However, this must be weighed against the needs and limitations of the payer, whether that is a healthcare system, an insurer, or the patient themselves. In order to find an optimal balance between the two, it’s becoming increasingly important for dental professionals to develop strong literacy in the economics of dental health.
Prof. Dr. Falk Schwendicke, Professor and Director of the Clinic for Conservative Dentistry and Pedodontology at Ludwig Maximilian University, says: “At the end of the day, the practice is an economic entity, and we need to be able to show patients, insurers, and funders that what we do is worthwhile, not just clinically but economically.”
In recent years, dental professionals have begun to shift away from procedures like root canal treatment and pulpectomy in favour of more conservative and minimally invasive approaches geared towards preserving tooth vitality. One such approach is vital pulp therapy (VPT).
VPT is a collection of techniques aimed at protecting vital pulp and facilitating healing in cases of deep carious lesions or accidental pulp exposure.
VPT preserves the developmental, defensive, and proprioceptive functions of the pulp tissue and helps to keep patients out of what Prof. Dr. Schwendicke refers to as the ‘death spiral’ of increasingly invasive treatments.5 It’s also considered technically easier to perform than root canal or pulpectomy treatments. But does saving the pulp have economic benefits as well as clinical benefits?
Despite the millions of dollars presumably spent in the field – the American Association of Endodontists (AAE) reports that 41,000 root canals are performed every day in the United States, with the average endodontist performing 25 per week6 – Dr Schwendicke says that research into the economics of endodontic interventions is sparse compared to fields like cariology and periodontology. That’s something Dr Schwendicke has been working to change.
Back in 2013, Prof. Dr. Schwendicke and colleagues created a decision model on the treatment of deep caries lesions.7 Decision models are mathematical models designed to mimic real-world scenarios and outcomes based on the synthesis of all available clinical data. While clinical trials can tell us about immediate outcomes, decision modelling can help us to map the full lifetime of an intervention, with all of its potential outcomes and their costs, to understand the optimal pathway of care.
In Prof. Dr. Schwendicke’s 2013 decision model, the research team compared the long-term cost-effectiveness of non-selective caries removal (referred to as ‘complete’ in the research), selective (‘incomplete’) one-step removal, and selective two-step removal.
The model showed that one-step selective removal was by far the most cost-effective intervention, and also the most successful in maintaining pulp vitality and retaining the tooth. According to Prof. Dr. Schwendicke, this shows that keeping invasiveness to a minimum early on has a big impact on long-term cost-effectiveness and clinical outcomes.
Building on this research in 2014, Prof. Dr. Schwendicke and Dr. Michael Stolpe used decision modelling to compare the most cost-effective intervention when the pulp was exposed: direct pulp capping or root canal treatment.8 This is an important question for endodontists because teeth treated with direct pulp capping do sometimes go on to require root canal treatment. When the root canal could have been performed immediately, with potentially better outcomes, the use of direct pulp capping must be justified.
The model showed that, despite requiring follow-up treatment earlier than teeth treated with a root canal, those treated with direct pulp capping were retained for a longer period of 52 years. This was achieved at a significantly lower lifetime cost of €545, compared to €701 for teeth treated with a root canal.
When the pulp cannot be saved, the economics of treatment become less clear-cut. A 2024 decision model study compared the cost-effectiveness of pulpotomy vs root canal treatment in teeth with irreversible pulpitis, finding that root canal treatment was the more expensive – but more successful – treatment option.9
In this case, cost-effectiveness came down to willingness to pay. When the payer was prepared to spend less money, pulpotomy was considered the most cost-effective over the patient’s lifetime. But if the payer was prepared to pay more for the root canal, the long-term benefits were considered to be worth the initial higher cost investment.
Broadly speaking, the research shows that the earlier we intervene with pulp-preserving measures like selective caries removal and VPT, the more cost-effective and clinically beneficial they are compared to root canal treatment. As the patient gets further along the treatment path, however, trade-offs must be made in order to achieve value.
Dr Schwendicke says: “It comes back to this ‘death spiral.’ The more invasive we get with endodontics, the harder the economic balances get. The endodontic interventions get more expensive, and at some point, it gets harder and harder to justify retaining the tooth. The balance can easily tilt to the point where, for example, an implant actually becomes the cost-effective choice. Maintaining the pulp can keep us out of the spiral altogether.”
Biodentine® is a hydraulic calcium silicate cement that is particularly well-suited for use in vital pulp therapies. Although Biodentine® was not part of this specific study, it offers practitioners a lower upfront cost than MTA – without compromising on clinical effectiveness. In fact, Biodentine® has completely reshaped the field of restorative dentistry with dual therapeutic and restorative properties way beyond those achieved by MTA. It has demonstrated a success rate of 95.8% for indirect pulp capping10, 96.4% for direct pulp capping11, and 93.9% for pulpotomy.12 Here’s how Biodentine® has been helping both general dentists and endodontic specialists to deliver better value for money while maintaining pulp vitality.
The ESE recommends hydraulic calcium silicate cements like Biodentine® over other materials, such as glass ionomer cement (GIC), for direct placement over the pulp, thanks to its superior ability to promote pulp healing and remineralise carious dentine.13-16
Biodentine® preserves pulp vitality by stimulating the pulp’s own natural healing capabilities.14 Unlike other tricalcium silicate materials that are based on Portland cement and often contain toxic trace elements from manufacturing, Biodentine® is made with proprietary Active Biosilicate TechnologyTM to guarantee a material of the utmost purity.17,18 It therefore has no cytotoxic, mutagenic, sensitising, or irritant effects on exposed pulp, ensuring high cell viability and enhancing biological healing.14
Biodentine® has been shown to support increased mineral deposition in the dentine, leading to the formation of thicker, denser layers of tertiary dentine compared to GIC, MTA, and CH.19-22 Although GIC and Biodentine® have both been shown to remineralise caries-affected (firm) dentine, only Biodentine® was able to significantly remineralise caries-infected (soft) dentine.23 By preserving more natural dentine, Biodentine® supports a more minimally invasive – and therefore cost-effective – approach.
Obtaining a tight seal and preventing bacterial infiltration are critical to the success and longevity of any vital pulp treatment.
Biodentine® achieves superior adhesion to the dentine surface by creating mineral tags into the openings of the dentina™ tubules17, forming a tight interface, a firm bond, and a good seal.14 Biodentine™ demonstrates superior marginal sealing and adaptation, establishing itself as the most effective dentin substitute under composite resin when compared to MTA and GIC. Its placement beneath the composite resin reduces polymerization shrinkage, enhancing the overall integrity of the restoration.24
Of course, by leaving behind carious dentine, as per the selective removal technique, it is understood that bacteria will also be left behind. However, the high alkaline pH of Biodentine® is highly unfavourable for bacterial proliferation, effectively disinfecting the carious dentine once placed.14,25
In order for the pulp to heal, it is important that the chosen material is strong enough to protect it from occlusal forces. Biodentine® is very similar to natural dentine in microhardness and compressive strength, and is superior to GIC in both.17 In the posterior teeth, where the occlusal forces are greatest, Biodentine® has proven to be a reliable temporary enamel restoration to allow for pulp healing for up to six months.26 In addition, its unique physiomechanical properties make it suitable for use as a permanent dentine substitute under final composite restoration.
In addition to remarkable clinical outcomes, Biodentine® can improve cost-effectiveness in the practice by simplifying procedures and streamlining workflows. It can be used in one-step cavity filling from pulp to crown in the Bio-Bulk Fill procedure, even when the pulp is exposed, and it can be covered with a final restoration in the same session. With no need for second visits and re-entry, that means fewer appointments and less time in the chair.
Although he hopes to see even more research on the cost-effectiveness of vital pulp therapies, Prof. Dr. Schwendicke says that the evidence so far is clear: “Maintaining pulp vitality is cost-effective and preferable to root canal treatment. Saving the pulp is not only clinically valid, it’s also economically valid.” With over 1,500 published studies* and counting demonstrating its clinical benefits, it’s clear that Biodentine® is the suitable material to help dentists and endodontists to achieve this. As it becomes increasingly important for endodontics to prove its value to funders, insurers, and the patients themselves, saving the pulp with Biodentine® is a clinically and economically smart decision for every practitioner.
*Publications available at https://pubmed.ncbi.nlm.nih.gov/
World Health Organization (WHO). Global oral health status report: Towards universal health coverage for oral health by 2030. https://www.who.int/team/noncommunicable-diseases/global-status-report-on-oral-health-2022. Published 18 November 2022
Heidelberg University Hospital. Oral diseases cost the world $710 billion annually. Newsroom. https://www.klinikum.uni-heidelberg.de/newsroom/en/oral-diseases-cost-the-world-710-billion-annually/. Published November 14, 2024.
European Federation of Periodontology (EFP). White paper: Oral health in comprehensive health – The EFP’s manifesto. EFP. https://www.efp.org/fileadmin/uploads/efp/Documents/Other_publications/EIxEFP_-_Oral_Health_white_paper_FINAL.pdf.”
British Dental Association (BDA). A billion in cuts. BDA News and Opinion. https://www.bda.org/news-and-opinion/news/a-billion-in-cuts/. Published January 25, 2024.
Sign up now and get an exclusive access to: